Literature DB >> 8199180

Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects.

T D Watson1, M J Caslake, D J Freeman, B A Griffin, J Hinnie, C J Packard, J Shepherd.   

Abstract

Human low-density lipoproteins (LDLs) comprise a spectrum of particles that vary in size, density, chemical composition, metabolic behavior, and atherogenicity. To identify determinants of this heterogeneity, we measured the percent distribution and plasma concentration of the three major LDL subfractions in 34 young healthy subjects. These parameters were correlated in univariate and multivariate analyses with various body and lifestyle factors; plasma lipids and lipoprotein; and the activities of cholesteryl ester transfer protein, lipoprotein lipase, and hepatic lipase (HL). Women (n = 15) had significantly more large, buoyant LDL (LDL-I; density, 1.025 to 1.034 g/mL) and high-density lipoprotein2 (HDL2) than men (n = 19). Both the percentage and concentration of LDL-I were correlated negatively with very-low-density lipoprotein triglycerides (VLDL-TG) and HL; they were correlated positively with HDL-cholesterol (HDL-C) and HDL2. In addition, percent LDL-I was negatively correlated with plasma triglycerides, VLDL-C, LDL-C, and apo-lipoprotein (apo) B concentrations. The concentrations of intermediate and small, dense LDL (LDL-II and LDL-III; density, 1.034 to 1.044 and 1.044 to 1.060 g/L, respectively) were positively correlated with LDL-C. LDL-III concentrations were also related to plasma cholesterol and apoB concentrations and HL activity. On multivariate analyses, approximately one third of the variability in LDL-I was explained by HL and plasma triglycerides. More than 80% of the variation in LDL-II was accounted for by a model that combined LDL-C and plasma apoB with body mass index and VLDL-TG.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199180     DOI: 10.1161/01.atv.14.6.902

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  12 in total

1.  Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.

Authors:  Peng Yang; Papasani V Subbaiah
Journal:  Biochim Biophys Acta       Date:  2015-07-18

2.  Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia.

Authors:  Noha A Yousri; Karsten Suhre; Esraa Yassin; Alya Al-Shakaki; Amal Robay; Maha Elshafei; Omar Chidiac; Steven C Hunt; Ronald G Crystal; Khalid A Fakhro
Journal:  Diabetes       Date:  2022-02-01       Impact factor: 9.461

3.  Mouse hepatic lipase alleles with variable effects on lipoprotein composition and size.

Authors:  Serena M Pratt; Sally Chiu; Glenda M Espinal; Noreene M Shibata; Howard Wong; Craig H Warden
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

4.  Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  Jyoti Malhotra; Emily S Tonorezos; Marina Rozenberg; Gloria L Vega; Charles A Sklar; Joanne Chou; Chaya S Moskowitz; Debra A Eshelman-Kent; Peter Janiszewski; Robert Ross; Kevin C Oeffinger
Journal:  J Lipid Res       Date:  2012-09-13       Impact factor: 5.922

5.  Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles.

Authors:  Chika Kinoshita; Tomohisa Nagano; Nobuyoshi Seki; Yoichi Tomita; Tomonori Sugita; Yuta Aida; Munenori Itagaki; Kenichi Satoh; Satoshi Sutoh; Hiroshi Abe; Akihito Tsubota; Yoshio Aizawa
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

6.  Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

Authors:  F Magkos; B S Mohammed; B Mittendorfer
Journal:  Int J Obes (Lond)       Date:  2008-09-09       Impact factor: 5.095

7.  Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles.

Authors:  Vasilis Tsimihodimos; Irene Gazi; Christina Kostara; Alexandros D Tselepis; Moses Elisaf
Journal:  Lipids       Date:  2007-04-11       Impact factor: 1.880

Review 8.  Parturition dysfunction in obesity: time to target the pathobiology.

Authors:  Nicole S Carlson; Teri L Hernandez; K Joseph Hurt
Journal:  Reprod Biol Endocrinol       Date:  2015-12-18       Impact factor: 5.211

9.  Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester.

Authors:  Barbara J Meyer; Frances M Stewart; Elizabeth A Brown; Josephine Cooney; Solveig Nilsson; Gunilla Olivecrona; Jane E Ramsay; Bruce A Griffin; Muriel J Caslake; Dilys J Freeman
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

Review 10.  Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit.

Authors:  Fergus McTaggart; Peter Jones
Journal:  Cardiovasc Drugs Ther       Date:  2008-06-14       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.